Pennsylvanian Jury Awards $3.6 Million Verdict in Actos Trial

On February 12, 2015, a Philadelphia jury awarded a $3.6 million dollar verdict, which included a $1.3 million punitive damage award, to John Kristufek, a former Pennsylvanian educator, who alleged that pharma giant Takeda Pharmaceutical Co.’s Actos diabetes drug was the cause of his bladder cancer. Click here to read the full article: Takeda Ordered [...]

March 17th, 2015|Actos Diabetes Drug|0 Comments

Takeda Held Responsible in First Federal Actos Bellwether Trial

After 34 days of trial, a Lafayette, Louisiana jury returned its verdict against Takeda and Lilly and ordered the PHARMA giants to pay $1.475 million in compensatory damages and $8 billion in punitive damages for injuries including bladder cancer to Terrance Allen, a hardware store manager, who took Actos for his diabetes treatment from 2004 [...]

Actos Trial Underway in Louisiana

Terry Allen, a retired hardware store manager is the plaintiff in the case currently in trial against pharmaceutical giant Takeda, the manufacturer of Actos, the diabetes drug that Allen and his experts say caused him to have bladder cancer. (See In Re Actos (Pioglitazone) Products Liability Litigation, 11-md-02299; Allen’s case is Allen v. Takeda Pharmaceuticals [...]

February 12th, 2014|Actos Diabetes Drug, Drug and Medical Device Litigation|0 Comments

Another Plaintiffs Actos verdict, Another Verdict Thrown Out by Trial Judge

On September 26, 2013, a jury in Baltimore, Maryland, found that Takeda Pharmaceutical Co. did not properly warn Diep An, an ex-U.S. Army translator, and his doctor about the risks of its Actos diabetes drug and ordered the company to pay more than $1.7 million in damages.  Jurors also found that An, a thirty year [...]

September 26th, 2013|Actos Diabetes Drug, Drug and Medical Device Litigation|0 Comments